NCT04348747 2026-05-11Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast CancerRoswell Park Cancer InstitutePhase 2 Recruiting23 enrolled